In a research report released yesterday, J.P.
On Tuesday, August 4, before market open, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) reported its second-quarter 2015 financial results that beat both top and bottom line expectations. The biotech giant, which recently …
J.P.
In a research report issued today, J.P.
Analysts are weighing in this afternoon on Gilead Sciences, Inc. (NASDAQ:GILD), after the U.
Shares of Juno Therapeutics Inc (NASDAQ:JUNO) closed yesterday up 15% following the announcement of the company’s collaboration with Celgene Corporation. In response, J.
In research report issued today, J.P.
Juno Therapeutics Inc (NASDAQ:JUNO) shares have taken off, adding 13.72% to trade at $60.
